van Dolleweerd C - Search Results

1

Passive immunity in the prevention of rabies.

Both L, Banyard AC, van Dolleweerd C, Horton DL, Ma JK, Fooks AR. Both L, et al. Among authors: van dolleweerd c. Lancet Infect Dis. 2012 May;12(5):397-407. doi: 10.1016/S1473-3099(11)70340-1. Lancet Infect Dis. 2012. PMID: 22541629 Review.

2

Monoclonal antibodies for prophylactic and therapeutic use against viral infections.

Both L, Banyard AC, van Dolleweerd C, Wright E, Ma JK, Fooks AR. Both L, et al. Among authors: van dolleweerd c. Vaccine. 2013 Mar 15;31(12):1553-9. doi: 10.1016/j.vaccine.2013.01.025. Epub 2013 Jan 29. Vaccine. 2013. PMID: 23370150 Free PMC article. Review.

3

Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans.

Both L, van Dolleweerd C, Wright E, Banyard AC, Bulmer-Thomas B, Selden D, Altmann F, Fooks AR, Ma JK. Both L, et al. Among authors: van dolleweerd c. FASEB J. 2013 May;27(5):2055-65. doi: 10.1096/fj.12-219964. Epub 2013 Jan 31. FASEB J. 2013. PMID: 23371065 Free PMC article.

4

Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody.

van Dolleweerd CJ, Teh AY, Banyard AC, Both L, Lotter-Stark HC, Tsekoa T, Phahladira B, Shumba W, Chakauya E, Sabeta CT, Gruber C, Fooks AR, Chikwamba RK, Ma JK. van Dolleweerd CJ, et al. J Infect Dis. 2014 Jul 15;210(2):200-8. doi: 10.1093/infdis/jiu085. Epub 2014 Feb 7. J Infect Dis. 2014. PMID: 24511101 Free PMC article.

5

Monoclonal antibodies for prophylactic and therapeutic use against viral infections.

Both L, Banyard AC, van Dolleweerd C, Wright E, Ma JK, Fooks AR. Both L, et al. Among authors: van dolleweerd c. Pediatr Pol. 2013 Sep-Oct;88(5):T15-T23. doi: 10.1016/j.pepo.2013.08.006. Epub 2013 Aug 23. Pediatr Pol. 2013. PMID: 32287402 Free PMC article. Review.

6

Molecular Pharming: future targets and aspirations.

Paul M, van Dolleweerd C, Drake PM, Reljic R, Thangaraj H, Barbi T, Stylianou E, Pepponi I, Both L, Hehle V, Madeira L, Inchakalody V, Ho S, Guerra T, Ma JK. Paul M, et al. Among authors: van dolleweerd c. Hum Vaccin. 2011 Mar;7(3):375-82. doi: 10.4161/hv.7.3.14456. Epub 2011 Mar 1. Hum Vaccin. 2011. PMID: 21368584 Free PMC article. Review.

7

Enhanced transport of plant-produced rabies single-chain antibody-RVG peptide fusion protein across an in cellulo blood-brain barrier device.

Phoolcharoen W, Prehaud C, van Dolleweerd CJ, Both L, da Costa A, Lafon M, Ma JK. Phoolcharoen W, et al. Among authors: van dolleweerd cj. Plant Biotechnol J. 2017 Oct;15(10):1331-1339. doi: 10.1111/pbi.12719. Epub 2017 Apr 19. Plant Biotechnol J. 2017. PMID: 28273388 Free PMC article.

8

Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice.

Stylianou E, Pepponi I, van Dolleweerd CJ, Paul MJ, Ma JK, Reljic R. Stylianou E, et al. Vaccine. 2011 Mar 9;29(12):2279-86. doi: 10.1016/j.vaccine.2011.01.030. Epub 2011 Jan 25. Vaccine. 2011. PMID: 21272603

9

Antibody degradation in tobacco plants: a predominantly apoplastic process.

Hehle VK, Paul MJ, Drake PM, Ma JK, van Dolleweerd CJ. Hehle VK, et al. Among authors: van dolleweerd cj. BMC Biotechnol. 2011 Dec 30;11:128. doi: 10.1186/1472-6750-11-128. BMC Biotechnol. 2011. PMID: 22208820 Free PMC article.

10

Immune-complex mimics as a molecular platform for adjuvant-free vaccine delivery.

Pepponi I, Stylianou E, van Dolleweerd C, Diogo GR, Paul MJ, Drake PM, Ma JK, Reljic R. Pepponi I, et al. Among authors: van dolleweerd c. PLoS One. 2013 Apr 23;8(4):e60855. doi: 10.1371/journal.pone.0060855. Print 2013. PLoS One. 2013. PMID: 23637771 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page